Bloomberg: “Ex-Trader Takes Sloan-Kettering toCourt Over Gene Therapy Deal”

Patrick Girondi claims cancer institute and Bluebird Bio conspired to quash his potential cure

By: Andrew Martin
October 29, 2020, 8:51 AM CDT

Patrick Girondi, a former commodities trader from Chicago, lives in Italy these days. But for the last couple of years, he’s been spending weeks at a time crashing at a friend’s apartment in Manhattan, waging a bare-knuckle and uphill legal battle against two well-regarded names in medical science: Bluebird Bio, a cutting edge gene-therapy company, and Sloan Kettering Institute, the research arm of the famous cancer center.

View the rest of the article here

View the PDF